IP Library Granted Patent US 8,343,964
Granted Patent B2
US 8,343,964 · App. 12/525,503 · Granted Jan 1, 2013

Indolic derivatives, their preparation processes and their uses in particular as antibacterials

Assignees: Universite Joseph Fourier; Centre National de la Recherche Scientifique
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,343,964
App. No.
12/525,503
Granted
Jan 1, 2013
Kind
B2
Abstract

The invention relates to the use of at least one compound of the formula (I), in which R and R 3 are particularly a hydrogen atom, R 1 is particularly a hydrogen atom or a methyl, ethyl or isobutyl mi group, R 4 , R 5 , R 6 and R 7 are independently a hydrogen atony, an alkoxyl group with 1 to 7 carbon atoms or a halogen atom, R 2 is a hydrogen atom, an O − group or an OH group, B is an N-GP 1 or NR c , group, GP 1 being a Boc or Cbz group, and R c is a hydrogen atom or a methyl or t-butyl group, for preparing a drug for treating conditions associated with bacterial infections, in particular for treating bacterial diseases.

Claims (50)

1. A method for the treatment of pathologies associated with Staphylococcus infections, comprising administering to a patient in need thereof at least one compound of formula (I):

wherein:

R represents

a hydrogen atom, or

an alkyl group comprising 1 to 7 carbon atoms, optionally substituted by a halogen;

R 3 represents a hydrogen atom;

R 4 and R 7 represent a hydrogen atom;

R 5 , and R 6 represent independently of each other:

a hydrogen atom;

an alkyl group comprising 1 to 4 carbon atoms;

a trifluoromethyl group;

an alkoxyl group comprising 1 to 7 carbon atoms;

a halogen atom of Br, Cl, F or I;

an amino group NH 2 ;

an N,N-dialkylamino group NR a R b , R a and R b representing independently of each other a hydrogen atom or an alkyl group comprising 1 to 4 carbon atoms;

R 1 represents:

an alkyl group comprising 1 to 6 carbon atoms;

a —(CH 2 ) m NH-GP group, m being 1 or 2, and GP representing Boc,

a —(CH 2 ) m NH 2 or —(CH 2 ) m NH 2 .X group, X representing HCl, HCOOH or HOOCCOOH, m being 1 or 2; or

an aryl group comprising 6 to 10 carbon atoms, optionally substituted by an NO 2 or methoxyl group;

R 2 represents:

a hydrogen atom;

an O − group;

an OH group;

COCH 2 ONH-Fmoc; or

OCOCH 3 ;

an alkoxyl group OR c , R c representing an alkyl group comprising 1 to 10 carbon atoms;

B represents:

a representing a single bond or a double bond;

A representing N or N + ; wherein

a represents a single bond when A represents N; and

a represents a double bond when A represents N + and R 2 represents O − ;

R′, R″ and R′″ representing, independently of each other:

a hydrogen atom; or

an alkoxyl group comprising 1 to 4 carbon atoms;

or the R′ and R″ groups representing together: o, p-dimethoxyl (2,4-dimethoxyl), di-m-dimethoxyl (3,5-dimethoxyl), or m, p-dimethoxyl (3,4-dimethoxyl), and R′″ then representing a hydrogen atom;

R IV representing:

a hydrogen atom,

GP 1 representing a Boc group; and

R c representing a hydrogen atom,

said compounds of formula (I) being able to be in the form of enantiomers including racemic mixtures, or in the form of salts of physiologically acceptable acids including hydrochlorides, formates or oxalates (HOOCCOOH).

2. The method according to claim 1 , comprising administering to the patient in need thereof at least one compound of formula (I), in combination with an antibiotic.

3. The method according to claim 2 , wherein said antibiotic is at least one selected from the group consisting of ciprofloxacin, norfloxacin, pefloxacin, enofloxacin, ofloxacin, levofloxacin and moxifloxacin.

4. The method according to claim 1 , wherein the compound of formula (I) corresponds to at least one compound selected from the group consisting of:

5. The method according to claim 1 , wherein R is a propyl group substituted by a Cl atom.

6. The method according to claim 1 , wherein R 5 is CH 3 or OCH 3 .

7. The method according to claim 1 , wherein R 5 or R 6 is N,N-dimethylamino.

8. The method according to claim 1 , wherein R 1 is a phenyl group substituted with an NO 2 group.

9. The method according to claim 1 , wherein R 2 is OCH 3 .

10. The method according to claim 1 , wherein the compound of formula (I) corresponds to at least one compound selected from the group consisting of:

Assignments (2)
MERGER Recorded Jun 2, 2022
From: UNIVERSITÉ JOSEPH FOURIER
To: UNIVERSITE GRENOBLE ALPES
Reel/Frame 060085/0060 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2012
From: DENIS, JEAN-NOEL MARIE, LEON; GUINCHARD, XAVIER JEAN, GEORGES, MARIE; MOREAU BORN LAFFONT, NICOLE JEANNE; NEUVILLE, LUC; VALLEE, YANNICK
To: UNIVERSITE JOSEPH FOURIER; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Reel/Frame 029153/0577 →
Priority Claims (1)
FR 07 00717 · Feb 1, 2007 · national
Continuity (1)
Related Publication 20100144726A1 · Jun 10, 2010